Hyalo Technologies is a Biotech & Pharmaceutical company establishing the next generation of drug delivery with the aim to develop a product to help clinicians address limited drug delivery options that are available to administer to patients. The company strives to leverage technology and research to effectively enhance efficacy and therapeutic effect.
Through its innovative nanotechnology drug delivery system, Hyalo Technologies will be able to drastically reduce systemic side effects and increase patient compliance. This is accomplished through a revolutionary drug delivery system that offers Target-Specific drug delivery, Time-Controlled drug release, Sequential Drug Delivery Intelligence, and 100% biodegradability.
Hyalo Technologies is open to collaborations such as Joint Ventures with established biotech and pharmaceutical companies to produce and market our products globally. Our Vision is to design and develop innovative healthcare products, which are of the highest caliber, quality and safety. Hyalo Technologies R&D labs and corporate offices are based in Philadelphia, Pennsylvania USA.